Article Text
Research letter
Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products
Statistics from Altmetric.com
Footnotes
Funding Our research on smokeless tobacco is supported by grants CA-81301, CA-141531, CA-1135884, and DA-013333 from the US National Institutes of Health.
Competing interests SSH is a witness for the plaintiff in a smokeless tobacco case. DKH has a grant from Nabi Biopharmaceuticals to conduct a clinical trial for the nicotine vaccine.
Provenance and peer review Not commissioned; externally peer reviewed.